跳至主要内容
临床试验/NCT04549818
NCT04549818Unknown不适用

Does Sacral Neuromodulation Relieve Chronic Pelvic Cancer Pain, Compared With Medical Treatment?

Assiut University0 个研究点目标入组 44 人开始时间: 2020年9月10日最近更新:
适应症

试验速览

阶段
不适用
入组人数
44
主要终点
The change of intensity of pain

研究概览

简要总结

in this trial, we will test the analgesic efficacy of sacral neuromodulation for patients with pelvic cancer, complaining of chronic pelvic pain in comparison to medical treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age, 18-70
  • Pain localized to the pelvic and perineal region
  • The pain is due to pelvic cancer or chronic pelvic pain after pelvic surgery for cancer
  • The intensity of pain assessed by VAS (visual analogue pain scale) > 7
  • Importantly, the included participants should gain > 50% reduction of their pain in response to sacral roots block, S2,3 and 4 with bupivacaine 0.5%, 2 ml for each root

排除标准

  • Coagulopathy
  • Infection at site of maneuver
  • Abnormal Psychological behavior that interfere with integrity of obtained data

结局指标

主要结局

The change of intensity of pain

时间窗: The outcome will be measured at day 15 postoperatively.

The intensity of pain measured by VAS pain score (visual analogue pain scale) where 0= no pain and 10=the maximum tolerated pain

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Diab Fuad Hetta

anesthesia dep. south egypt cancer institute, El methaque st., assuit city, Egypt

Assiut University

相似试验

Analgesic Efficacy of Sacral Neuromodulation for... | 临床试验